Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ruxolitinib in severe COVID-19: Results of a multicenter, prospective, single arm, open-label clinical study to investigate the efficacy and safety of ruxolitinib in patients with COVID-19 and severe acute respiratory syndrome.
Rev Fac Cien Med Univ Nac Cordoba. 2021 Sep 7;78(3):294-302. doi: 10.31053/1853.0605.v78.n3.32800.
Rev Fac Cien Med Univ Nac Cordoba. 2021.
PMID: 34617700
Free PMC article.
Clinical Trial.
Cite
Cite